We are live on ! Find out more
PHGE.WS

BiomX Inc. Warrants to purchase one-half of a share of Common Stock

Delisted

PHGE.WS was delisted on the 1st of June, 2023.

8 hedge funds and large institutions have $40K invested in BiomX Inc. Warrants to purchase one-half of a share of Common Stock in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

10% less capital invested

Capital invested by funds: $44.2K → $40K (-$4.22K)

11% less funds holding

Funds holding: 98 (-1)

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
8
Holders Change
-1
Holders Change %
-11.11%
% of All Funds
0.13%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
1
Reduced
3
Closed
1
Calls
Puts
Net Calls
Net Calls Change

PHGE.WS Hedge Fund Activity: Q1 2023 in Review

8 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in BiomX Inc. Warrants to purchase one-half of a share of Common Stock (PHGE.WS) for Q1 2023, worth a combined $40K — down 9.5% from $44.2K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of PHGE.WS and 0 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 1 added.

The largest buyer was Walleye Capital, adding an estimated $150. The largest seller was BlueCrest Capital Management, exiting entirely with an estimated $1.61K sold.

  • 8 institutional investors held BiomX Inc. Warrants to purchase one-half of a share of Common Stock (PHGE.WS) as of Q1 2023, down from 9 in Q4 2022.
  • Funds reported $40K of BiomX Inc. Warrants to purchase one-half of a share of Common Stock stock for Q1 2023, down 9.5% quarter-over-quarter.
  • 0 funds opened new BiomX Inc. Warrants to purchase one-half of a share of Common Stock positions in Q1 2023 and 1 closed out, a net change of -1 holder.
  • The largest BiomX Inc. Warrants to purchase one-half of a share of Common Stock buyer in Q1 2023 was Walleye Capital, an estimated $150 added.
  • The largest BiomX Inc. Warrants to purchase one-half of a share of Common Stock seller in Q1 2023 was BlueCrest Capital Management, an estimated $1.61K sold.

Based on aggregated 13F filings for Q1 2023.